Literature DB >> 6142511

Direct effects of adriamycin on the rat heart sarcolemma.

P K Singal, V Panagia.   

Abstract

Effects of adriamycin on rat heart sarcolemma were investigated by determining several membrane enzyme activities in the absence or presence of different concentrations of the drug. The adenylate cyclase activity was found to be stimulated by 0.001 and 0.01 microM of adriamycin whereas this enzyme activity was inhibited at 100 and 1000 microM concentrations of the drug. Magnesium dependent Na+, K+ ATPase was not effected by adriamycin, however, in presence of 2 mM ouabain, adriamycin (100 microM) had a depressant effect on the Na+, K+ ATPase activity. Ca2+ ATPase activity was found to be stimulated by adriamycin. The drug had no effect on the Mg2+ ATPase and 5'-nucleotidase activities. These data suggest direct as well as specific effects of adriamycin which may be important in drug-induced cardiotoxicity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6142511

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  16 in total

1.  Subcellular basis of vitamin C protection against doxorubicin-induced changes in rat cardiomyocytes.

Authors:  Ana Ludke; Anita K Sharma; Ashim K Bagchi; Pawan K Singal
Journal:  Mol Cell Biochem       Date:  2011-09-22       Impact factor: 3.396

2.  Significance of adaptation mechanisms in adriamycin induced congestive heart failure.

Authors:  P K Singal; N Siveski-Iliskovic; N Kaul; M Sahai
Journal:  Basic Res Cardiol       Date:  1992 Nov-Dec       Impact factor: 17.165

3.  Lipid lowering: an important factor in preventing adriamycin-induced heart failure.

Authors:  N Iliskovic; P K Singal
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

4.  Effects of cardiac-restricted overexpression of the A(2A) adenosine receptor on adriamycin-induced cardiotoxicity.

Authors:  Eman A Hamad; Xue Li; Jianliang Song; Xue-Qian Zhang; Valerie Myers; Hajime Funakoshi; Jin Zhang; Jufang Wang; Jifen Li; David Swope; Ashley Madonick; John Farber; Glenn L Radice; Joseph Y Cheung; Tung O Chan; Arthur M Feldman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-02       Impact factor: 4.733

5.  Induction of caspase-independent apoptosis in H9c2 cardiomyocytes by adriamycin treatment.

Authors:  Ho-Joong Youn; Ho-Shik Kim; Mi-Hee Jeon; Jung-Hee Lee; Yun-Jee Seo; Yong-Joon Lee; Jeong-Hwa Lee
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

6.  Effects of PPARα/PGC-1α on the energy metabolism remodeling and apoptosis in the doxorubicin induced mice cardiomyocytes in vitro.

Authors:  Yongyao Yang; Hongming Zhang; Xiaoyan Li; Tianhe Yang; Qingan Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

7.  Adriamycin depresses in vivo and in vitro phosphatidylethanolamine N-methylation in rat heart sarcolemma.

Authors:  N Iliskovic; V Panagia; J Slezák; D Kumar; T Li; P K Singal
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

Review 8.  Doxorubicin-induced apoptosis: implications in cardiotoxicity.

Authors:  B Kalyanaraman; Joy Joseph; Shashi Kalivendi; Suwei Wang; Eugene Konorev; Srigiridhar Kotamraju
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

9.  Relative cardiotoxicity and cytotoxicity of anthraquinonyl glucosaminosides.

Authors:  J W Banning; H N Abramson; H C Wormser; J D Wu; T H Corbett
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

10.  Effect of phenytoin on the pharmacokinetics of doxorubicin and doxorubicinol in the rabbit.

Authors:  B J Cusack; D A Tesnohlidek; V L Loseke; R E Vestal; D E Brenner; R D Olson
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.